1. Home
  2. MNOV vs ASRT Comparison

MNOV vs ASRT Comparison

Compare MNOV & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • ASRT
  • Stock Information
  • Founded
  • MNOV 2000
  • ASRT 1995
  • Country
  • MNOV United States
  • ASRT United States
  • Employees
  • MNOV N/A
  • ASRT N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNOV Health Care
  • ASRT Health Care
  • Exchange
  • MNOV Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • MNOV 76.0M
  • ASRT 65.7M
  • IPO Year
  • MNOV 2005
  • ASRT 1997
  • Fundamental
  • Price
  • MNOV $1.34
  • ASRT $0.68
  • Analyst Decision
  • MNOV Strong Buy
  • ASRT Strong Buy
  • Analyst Count
  • MNOV 1
  • ASRT 3
  • Target Price
  • MNOV $9.00
  • ASRT $3.08
  • AVG Volume (30 Days)
  • MNOV 14.3K
  • ASRT 414.9K
  • Earning Date
  • MNOV 05-08-2025
  • ASRT 05-05-2025
  • Dividend Yield
  • MNOV N/A
  • ASRT N/A
  • EPS Growth
  • MNOV N/A
  • ASRT N/A
  • EPS
  • MNOV N/A
  • ASRT N/A
  • Revenue
  • MNOV N/A
  • ASRT $124,961,000.00
  • Revenue This Year
  • MNOV N/A
  • ASRT N/A
  • Revenue Next Year
  • MNOV N/A
  • ASRT $11.20
  • P/E Ratio
  • MNOV N/A
  • ASRT N/A
  • Revenue Growth
  • MNOV N/A
  • ASRT N/A
  • 52 Week Low
  • MNOV $1.12
  • ASRT $0.65
  • 52 Week High
  • MNOV $2.55
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 28.65
  • ASRT 38.24
  • Support Level
  • MNOV $1.44
  • ASRT $0.65
  • Resistance Level
  • MNOV $1.53
  • ASRT $0.80
  • Average True Range (ATR)
  • MNOV 0.05
  • ASRT 0.05
  • MACD
  • MNOV -0.00
  • ASRT -0.00
  • Stochastic Oscillator
  • MNOV 11.11
  • ASRT 22.00

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: